TY - JOUR
T1 - Mutational founder effect in recessive dystrophic epidermolysis bullosa families from Southern Tunisia
AU - Ben Brick, Ahlem Sabrine
AU - Laroussi, Nadia
AU - Mesrati, Hela
AU - Kefi, Rym
AU - Bchetnia, Mbarka
AU - Lasram, Khaled
AU - Ben Halim, Nizar
AU - Romdhane, Lilia
AU - Ouragini, Houyem
AU - Marrakchi, Salaheddine
AU - Boubaker, Mohamed Samir
AU - Meddeb Cherif, Mounira
AU - Castiglia, Daniele
AU - Hovnanian, Alain
AU - Abdelhak, Sonia
AU - Turki, Hamida
PY - 2014
Y1 - 2014
N2 - Dystrophic epidermolysis bullosa (DEB) is a group of heritable bullous skin disorders caused by mutations in the COL7A1 gene. One of the most severe forms of DEB is the severe generalized [recessive dystrophic epidermolysis bullosa (RDEB-SG)] subtype, which is inherited in an autosomal recessive manner. This subtype is most often due to COL7A1 mutations resulting in a premature termination codon on both alleles. We report here, the molecular investigation of 15 patients belonging to 14 nuclear families from the city of Sfax in Southern Tunisia, with clinical features of RDEB-SG complicated by squamous cell carcinoma in 3 patients. We identified two novel mutations, p.Val769LeufsX1 and p.Ala2297SerfsX91, in addition to one previously reported mutation (p.Arg2063Trp). The p.Val769LeufsX1 mutation was shared by 11 families and haplotype analysis indicated that it is a founder mutation. The p.Ala2297SerfsX91 mutation was a private mutation found in only one family. Together with the previously described recurrent mutations in Tunisia, screening for the founder p.Val769LeufsX1 mutation should provide a rapid molecular diagnosis tool for mutation screening in RDEB patients from Southern Tunisia and possibly from other Mediterranean populations sharing the same genetic background.
AB - Dystrophic epidermolysis bullosa (DEB) is a group of heritable bullous skin disorders caused by mutations in the COL7A1 gene. One of the most severe forms of DEB is the severe generalized [recessive dystrophic epidermolysis bullosa (RDEB-SG)] subtype, which is inherited in an autosomal recessive manner. This subtype is most often due to COL7A1 mutations resulting in a premature termination codon on both alleles. We report here, the molecular investigation of 15 patients belonging to 14 nuclear families from the city of Sfax in Southern Tunisia, with clinical features of RDEB-SG complicated by squamous cell carcinoma in 3 patients. We identified two novel mutations, p.Val769LeufsX1 and p.Ala2297SerfsX91, in addition to one previously reported mutation (p.Arg2063Trp). The p.Val769LeufsX1 mutation was shared by 11 families and haplotype analysis indicated that it is a founder mutation. The p.Ala2297SerfsX91 mutation was a private mutation found in only one family. Together with the previously described recurrent mutations in Tunisia, screening for the founder p.Val769LeufsX1 mutation should provide a rapid molecular diagnosis tool for mutation screening in RDEB patients from Southern Tunisia and possibly from other Mediterranean populations sharing the same genetic background.
KW - COL7A1
KW - Founder effect
KW - Novel mutations
KW - Recessive dystrophic epidermolysis bullosa severe generalized
UR - http://www.scopus.com/inward/record.url?scp=84900833367&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84900833367&partnerID=8YFLogxK
U2 - 10.1007/s00403-013-1421-y
DO - 10.1007/s00403-013-1421-y
M3 - Article
C2 - 24170138
AN - SCOPUS:84900833367
SN - 0340-3696
VL - 306
SP - 405
EP - 411
JO - Archives of Dermatological Research
JF - Archives of Dermatological Research
IS - 4
ER -